|
Market Cap (5-Jun) $15,812,900 (1,318th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 2,106,389 |
Shortsold (23-Jan) 143,231 (0.01%) (538th) |
|
52w High $0.029 |
52w Low $0.010 |
P/E - |
EPS 0 |
NTI released this announcement to the ASX on 23 November 2020, 17:15. The announcement is not marked as price sensitive, and is 20 page(s) in length and 898.36kb in size.
You can view all announcements from NTI and see how they appear on a price chart on the announcements page.
At the date of this announcement, NTI was 0.001% short sold according to ASIC data. It was ranked the 607th most shorted stock on the ASX. It is now ranked as the 538th most shorted stock on the ASX with 0.011% of total shares short sold as of the latest reported data (23 January 2026).
| Other Recent Announcements from NTI | |
|---|---|
| Notification of cessation of securities - NTI | 30 June 2023, 17:06 |
| Notification regarding unquoted securities - NTI | 28 June 2023, 16:14 |
| NTI to Present at Rett Syndrome Foundation Meeting | 5 June 2023, 8:27 |
| Notice of General Meeting/Proxy Form | 23 November 2020, 17:15 |
| Initiation of Clinical Product Formulation Studies | 19 November 2020, 8:28 |
| Investor Presentation | 16 November 2020, 8:33 |
| Ceasing to be a substantial holder x2 | 13 November 2020, 18:21 |
You must be logged in to post a reply.
Neurotech International 